Dissertation Awards
2012 (Cycle 21)
| Signaling pathways in tobacco-induced vascular dysfunction | 2012 (Cycle 21) | $60,000 |
| University of California, San Diego | Early Diagnosis/Pathogenesis | |
| Lung cancer initiation by inflammatory proteins | 2012 (Cycle 21) | $60,000 |
| University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
| Built Environment and Tobacco Use in Homeless Shelters | 2012 (Cycle 21) | $60,000 |
| University of California, Los Angeles | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2011 (Cycle 20)
| A Novel Anti-Cancer Therapy: Inhibition of MUS81-EME1 | 2011 (Cycle 20) | $60,000 |
| University of California, Davis | Cancer | |
| Predicting bone teratogenicity of tobacco products in vitro | 2011 (Cycle 20) | $59,825 |
| University of California, Riverside | General Biomedical Science | |
| Study of TSNA Signaling Pathway by Targeted Proteomics | 2011 (Cycle 20) | $60,000 |
| University of California, Riverside | General Biomedical Science | |
| Smoking and Post-traumatic Growth Among High Risk Youth | 2011 (Cycle 20) | $59,900 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| De-silencing hypermethylated tumor supressor genes | 2011 (Cycle 20) | $60,000 |
| California Institute of Technology | Pulmonary Disease | |
2010 (Cycle 19)
| In search of a complement system inhibitor targeting C5aR | 2010 (Cycle 19) | $60,000 |
| University of California, Riverside | General Biomedical Science | |
| Replication Studies of Minor-Groove DNA Adducts | 2010 (Cycle 19) | $60,000 |
| University of California, Riverside | Cancer | |
| Syntheis of the anti-cancer norcembranoid inelegnolide | 2010 (Cycle 19) | $60,000 |
| University of California, Irvine | Cancer | |
| Adoption of Tobacco Programs in California Schools | 2010 (Cycle 19) | $58,750 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Notch Enhances Shear-Mediated Arteriogenesis in Cerebrum | 2010 (Cycle 19) | $60,000 |
| University of California, San Francisco | Cardiovascular Disease | |
| Investigating Tobacco Industry Research on Polonium-210 | 2010 (Cycle 19) | $60,000 |
| Stanford University | Public Health, Public Policy, and Economics | |
| HRQoL in Veterans with Chronic PTSD and Tobacco Dependence | 2010 (Cycle 19) | $59,300 |
| Alliant International University | Nicotine Dependence | |
2009 (Cycle 18)
| Inhibition of ERBB2 expression by polyamides in NSCLC | 2009 (Cycle 18) | $60,000 |
| California Institute of Technology | Cancer | |
| Repression of c-Jun oncogene activity in lung cancer | 2009 (Cycle 18) | $60,000 |
| California Institute of Technology | Cancer | |
| Genomic Profiles in Tobacco Related Metastatic Oral Cancer | 2009 (Cycle 18) | $30,000 |
| University of California, San Francisco | Cancer | |
| Cellular Analysis of BAVM Regression in a Mouse Model | 2009 (Cycle 18) | $60,000 |
| University of California, San Francisco | Cardiovascular Disease | |
| Molecular therapies against small cell lung cancer | 2009 (Cycle 18) | $60,000 |
| Stanford University | Cancer | |
| Synthesis of Spirolide-Activators of L-type Calcium Channels | 2009 (Cycle 18) | $60,000 |
| University of California, Santa Barbara | Cardiovascular Disease | |
| Histone Deacetylation and Anti-inflammatory Response of GR | 2009 (Cycle 18) | $60,000 |
| University of California, Berkeley | General Biomedical Science | |
| Synthesis of Anticancer Peroxides | 2009 (Cycle 18) | $58,332 |
| University of California, Irvine | Pulmonary Disease | |
| Reactivity of Addicted Users to Advertising Cues | 2009 (Cycle 18) | $30,000 |
| University of California, Irvine | Tobacco-Use Prevention and Cessation | |
| Inflammatory mediators & lung cancer progression | 2009 (Cycle 18) | $59,685 |
| University of California, Los Angeles | Cancer | |
| Fluorescent Probes for DNA Mismatch Detection | 2009 (Cycle 18) | $60,000 |
| California Institute of Technology | Cancer | |
2008 (Cycle 17)
| Regulation of Integrin Activation | 2008 (Cycle 17) | $60,000 |
| University of California, San Diego | Cardiovascular Disease | |
| Chromatin Remodeling in Glucocorticoid Resistance of COPD | 2008 (Cycle 17) | $60,000 |
| University of California, San Francisco | Pulmonary Disease | |
| Cigarette Smoking and Stress-Coping among Latino Youth | 2008 (Cycle 17) | $60,000 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Grainyhead-Like Transcription factor in Airway Epithelium | 2008 (Cycle 17) | $60,000 |
| University of California, Irvine | Pulmonary Disease | |
| Nicotinic Regulation of Neurogenesis in Adult Hippocampus | 2008 (Cycle 17) | $60,000 |
| University of California, San Diego | Nicotine Dependence | |
| Small molecule gene regulation in lung cancer cells | 2008 (Cycle 17) | $60,000 |
| California Institute of Technology | Cancer | |
| Synthesis and Evaluation of Telomerase Inhibitors | 2008 (Cycle 17) | $58,359 |
| University of California, Santa Barbara | General Biomedical Science | |
| Replication Recovery Through Recombination and Mus81-Mms4 | 2008 (Cycle 17) | $60,000 |
| University of California, Davis | General Biomedical Science | |
| Synthesis of the Glaciapyrroles, New Anticancer Agents | 2008 (Cycle 17) | $60,000 |
| University of California, Irvine | Cancer | |
2007 (Cycle 16)
| Size-segregated Chemical Composition of Tobacco Smoke | 2007 (Cycle 16) | $30,000 |
| University of California, Irvine | General Biomedical Science | |
| Total Synthesis of Anticancer Compounds: The Neomangicols | 2007 (Cycle 16) | $59,245 |
| University of California, Berkeley | General Biomedical Science | |
| NMR studies of the LDL receptor active conformation of ApoE | 2007 (Cycle 16) | $60,000 |
| University of California, Berkeley | Cardiovascular Disease | |
| Neural mechanisms underlying nicotine as a 'gateway' drug | 2007 (Cycle 16) | $60,000 |
| University of California, Irvine | Nicotine Dependence | |
2006 (Cycle 15)
| Tobacco smoke and oocyte differentiation from human ES cells | 2006 (Cycle 15) | $60,000 |
| University of California, San Francisco | General Biomedical Science | |
| Effects of nicotine on schizophrenia-like cognitive deficits | 2006 (Cycle 15) | $60,000 |
| University of California, San Diego | Nicotine Dependence | |
| Synthesis and Evaluation of Anticancer Agent Celogentin C | 2006 (Cycle 15) | $60,000 |
| Stanford University | General Biomedical Science | |
2005 (Cycle 14)
| Cell adhesion at nicotinic synapses | 2005 (Cycle 14) | $59,500 |
| University of California, San Diego | Nicotine Dependence | |
| Effects of side stream tobacco smoke on DNA deletions | 2005 (Cycle 14) | $60,000 |
| University of California, Los Angeles | Cancer | |
| Inhibition of cell death in head and neck cancer cells | 2005 (Cycle 14) | $30,000 |
| University of Southern California | Cancer | |
| Defining mutagenesis pathways in tobacco-related cancer | 2005 (Cycle 14) | $60,000 |
| Scripps Research Institute | Cancer | |
| Lung cancer treatment: The total synthesis of ineleganolide | 2005 (Cycle 14) | $59,700 |
| California Institute of Technology | General Biomedical Science | |
| Micro RNA and dopamine-induced dentritic protein synthesis | 2005 (Cycle 14) | $59,500 |
| California Institute of Technology | Nicotine Dependence | |
| A novel total synthesis of brazilin and brazilide A | 2005 (Cycle 14) | $59,500 |
| University of California, Santa Barbara | General Biomedical Science | |
| Nicotine synapse formation in the hippocampus | 2005 (Cycle 14) | $59,500 |
| University of California, San Diego | Nicotine Dependence | |
2004 (Cycle 13)
| Transcription factor modification: A role in lung cancer?" | 2004 (Cycle 13) | $60,000 |
| California Institute of Technology | Cancer | |
| Smoking, atherosclerosis and MCSF gene variations | 2004 (Cycle 13) | $59,988 |
| University of Southern California | Cardiovascular Disease | |
| Total synthesis of the clinical anticancer drug etoposide | 2004 (Cycle 13) | $90,000 |
| California Institute of Technology | General Biomedical Science | |
| Cognitive effects of gestational nicotine | 2004 (Cycle 13) | $60,000 |
| University of California, Irvine | General Biomedical Science | |
2003 (Cycle 12)
| Quantification of toxicants in harm reduction cigarettes | 2003 (Cycle 12) | $25,390 |
| University of California, Riverside | General Biomedical Science | |
| New methods for searching tobacco industry documents | 2003 (Cycle 12) | $60,000 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Latino and Asian American college students' smoking | 2003 (Cycle 12) | $60,000 |
| University of California, Riverside | Epidemiology | |
| Soluble homologs of the nicotinic receptor | 2003 (Cycle 12) | $53,046 |
| University of California, San Diego | Nicotine Dependence | |
| Implementation of tobacco prevention programming and smoking | 2003 (Cycle 12) | $59,070 |
| University of Southern California | Epidemiology | |
| Role of regulation orientation on framing antismoking ads | 2003 (Cycle 12) | $60,000 |
| University of California, Irvine | Public Health, Public Policy, and Economics | |
2002 (Cycle 11)
| Total Synthesis of Mitomycin C, an Anti-Cancer Therapeutic | 2002 (Cycle 11) | $60,000 |
| California Institute of Technology | Cancer | |
| The determinants of college smoking | 2002 (Cycle 11) | $59,798 |
| University of Southern California | Epidemiology | |
| Smoking, metabolic syndrome and subclinical atherosclerosis | 2002 (Cycle 11) | $48,089 |
| University of Southern California | Epidemiology | |
| Effective diffusion of evidence-based tobacco curricula | 2002 (Cycle 11) | $48,089 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Cigarette smoke, MCP-1 expression in vivo and atherogenesis | 2002 (Cycle 11) | $50,418 |
| University of California, Riverside | Cardiovascular Disease | |
| (-) Lobeline: total synthesis and derivitization | 2002 (Cycle 11) | $60,000 |
| California Institute of Technology | General Biomedical Science | |
2001 (Cycle 10)
| Effects of nicotine on taste processing | 2001 (Cycle 10) | $49,728 |
| University of California, Davis | Nicotine Dependence | |
| Long-term adherence after pulmonary rehabilitation for COPD | 2001 (Cycle 10) | $57,600 |
| University of California, San Diego | Pulmonary Disease | |
| Exploring transdisciplinary scientific collaboration | 2001 (Cycle 10) | $29,040 |
| University of California, Irvine | Public Health, Public Policy, and Economics | |
| The effect of depression and peer influences on smoking init | 2001 (Cycle 10) | $60,000 |
| University of Southern California | Epidemiology | |
2000 (Cycle 9)
| Mechanism of apparent long-term nicotinic inactivation | 2000 (Cycle 9) | $55,000 |
| University of California, Riverside | Nicotine Dependence | |
| Impact of nicotinic signaling on neuronal gene expression | 2000 (Cycle 9) | $56,000 |
| University of California, San Diego | Nicotine Dependence | |
| Nicotine regulation of the noradrenergic system | 2000 (Cycle 9) | $52,375 |
| University of California, Irvine | Nicotine Dependence | |
| Smoking in Asian youth: effect of self-image and family | 2000 (Cycle 9) | $60,000 |
| California School of Professional Psychology | Epidemiology | |
| Emotional intelligence and smoking across ethnicity | 2000 (Cycle 9) | $60,000 |
| University of Southern California | Epidemiology | |
| Patterns & risk factors for adolescent smoking progression | 2000 (Cycle 9) | $60,000 |
| University of Southern California | Epidemiology | |
| Relationships between smoking, homocysteine & folate | 2000 (Cycle 9) | $48,651 |
| University of California, San Diego | Epidemiology | |
| Effect of estrogen on ETS-induced glyco-oxidation | 2000 (Cycle 9) | $49,384 |
| University of California, Davis | Cardiovascular Disease | |
| Heat shock proteins as biomarkers of lung oxidant stress | 2000 (Cycle 9) | $30,000 |
| University of California, Davis | Pulmonary Disease | |
1999 (Cycle 8)
| Media and smoking among adolescent girls across ethnicity | 1999 (Cycle 8) | $65,200 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Nicotinic modulation of dopamine release during development | 1999 (Cycle 8) | $15,000 |
| University of California, Irvine | Nicotine Dependence | |
| Methyl-DNA Binding Protein Regulation and Function | 1999 (Cycle 8) | $39,918 |
| University of California, San Diego | General Biomedical Science | |
| Effects of Nicotine on Brain Development | 1999 (Cycle 8) | $64,000 |
| Cedars-Sinai Medical Center | Nicotine Dependence | |
| Environmental tobacco smoke effects on lung surfactant | 1999 (Cycle 8) | $40,000 |
| University of California, Santa Barbara | Pulmonary Disease | |
| Parental and Movie Influences on Adolescent Smoking Behavior | 1999 (Cycle 8) | $40,000 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| Pregnancy complications and chemokine expression in smokers | 1999 (Cycle 8) | $20,000 |
| University of California, San Francisco | General Biomedical Science | |
| Tobacco, Bacteria-Binding and Ca Signaling in Lung Epithelia | 1999 (Cycle 8) | $40,000 |
| University of California, Berkeley | Pulmonary Disease | |
| An RNA biomarker for tobacco smoke toxicity | 1999 (Cycle 8) | $61,500 |
| University of California, Davis | General Biomedical Science | |
| Modeling the relation of smoking to the ovarian function | 1999 (Cycle 8) | $36,691 |
| University of California, Davis | Epidemiology | |
| Nicotinic signaling through somatic spines | 1999 (Cycle 8) | $19,978 |
| University of California, San Diego | Nicotine Dependence | |